Bridging Gaps in LGMD Care
John Vissing, MD, DMSci
Conrad Weihl, MD, PhD
Recognizing Early Signs of LGMD2I/R9
Establishing Our Foundation of LGMD2I/R9
Integrating Perspectives: The Value of Patient and Caregiver Input
Navigating the LGMD2I/R9 Diagnostic Pathway
Advancing Care: Clinical Innovations on the Horizon
Optimizing Patient Management Strategies
Establishing Our Foundation of LGMD2I/R9: Unlocking the Genetics
The Role of Multidisciplinary Care in LGMD2I/R9
Driving Progress in Cardiology: Exploring the Role of FXI in Acute Coronary Syndromes & Beyond
C. Michael Gibson, MD, MS
Roxana Mehran, MD, FSCAI
Factoring Solutions to the Management of Stroke Care in the Settings of Secondary Prevention and AF
M. Edip Gurol, MD, MSc
Robin Novakovic, MD
Shadi Yaghi, MD
Jeffrey Weitz, MD
Autoantibodies in CIDP: Prevalence and Diagnostic Implications
Jeffrey Allen, MD
Nicholas J. Silvestri, MD
Incorporating FcRn Inhibitors Into Clinical Practice in Chronic Inflammatory Demyelinating Polyneuropathy
Novel Mechanisms of Action: FcRn Inhibitors
Clinical Benefits of FcRn Inhibitors: Innovations in CIDP Management and Treatment
Navigating CIDP Treatments: IVIg and Steroid Advantages and Limitations
Loading...
We're glad to see you're enjoying MedEd On The Go… but how about a more personalized experience?
Press cancel to remain on MedEd On The Go. Press the link below or the continue button to keep going.